Inhibition of Platelet Aggregation With Eptifibatide, Bivalirudin, and Heparin in Patients Undergoing Percutaneous Coronary Intervention Receiving Clopidogrel Pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel With Or Without INtegrilin

The present study assessed the magnitude of inhibition of platelet aggregation induced by adenosine diphosphate and thrombin receptor activating peptide achieved with unfractionated heparin, the direct thrombin inhibitor bivalirudin, and the glycoprotein IIb/IIIa inhibitor eptifibatide in patients w...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2005-06, Vol.95 (12), p.1453
Main Authors: Saucedo, Jorge F, Wady Aude, Pacheco, Rebecca, Thorn, Brett
Format: Article
Language:English
Subjects:
Comparative studies
Heart
Inhibitor drugs
Medical treatment
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study assessed the magnitude of inhibition of platelet aggregation induced by adenosine diphosphate and thrombin receptor activating peptide achieved with unfractionated heparin, the direct thrombin inhibitor bivalirudin, and the glycoprotein IIb/IIIa inhibitor eptifibatide in patients who underwent percutaneous coronary intervention and were treated with concomitant aspirin and clopidogrel. [PUBLICATION ABSTRACT]
ISSN:0002-9149
1879-1913